TrialGynecologic oncology2009

Sunitinib malate in the treatment of recurrent or persistent uterine leiomyosarcoma: a Gynecologic Oncology Group phase II study.

Martee L Hensley et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.